Synonyms
Status
Molecule Category Free-form
ATC C10AA04
UNII 4L066368AS

Structure

InChI Key FJLGEFLZQAZZCD-VAWYXSNFSA-N
Smiles CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
InChI
InChI=1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H26FNO4
Molecular Weight 411.47
AlogP 4.63
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 8.0
Polar Surface Area 82.69
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 30.0
Assay Description Organism Bioactivity Reference
In vitro inhibitory activity was evaluated on cholesterol biosynthesis in HepG2 cells Homo sapiens 28.0 nM
Inhibitory concentration against 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens 28.0 nM
Inhibition of pig DPP4 at 500 uM Sus scrofa 8.0 %
Inhibition of rat HMG-CoA reductase using 0.37 MBq DL-[3-14C]HMG-CoA Rattus norvegicus 3.0 nM
DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) None 400.0 nM
DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) Escherichia coli 0.353 nM
Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting Homo sapiens 80.1 %
Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 76.0 %
Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting Homo sapiens 98.2 %

Cross References

Resources Reference
ChEBI 38562
ChEMBL CHEMBL2220442
DrugBank DB01095
FDA SRS 4L066368AS
Guide to Pharmacology 2951
PubChem 1548972
SureChEMBL SCHEMBL2848
ZINC ZINC01886617